| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/16/2005 | EP1514558A1 Use of MARKK or MARKK antagonists for the treatment of pathologies characterised by increased or reduced phosphorylation of MARK or tau protein |
| 03/16/2005 | EP1514556A1 Botulinum toxin pharmaceutical compositions |
| 03/16/2005 | EP1514482A1 Milk fractions and milk preparations for treating and/or preventing COX-2 mediated diseases |
| 03/16/2005 | EP1514119A2 DIAGNOSTIC POLYMORPHISM OF 11s-HYDROXYSTEROID DEHYDROGENASE USEFUL FOR IDENTIFYING RISK OF DEVELOPING ALZHEIMER S DISEA SE |
| 03/16/2005 | EP1514116A1 Oxaliplatin anti-resistance agent |
| 03/16/2005 | EP1514114A2 Method to screen ligands using eukaryotic cell display |
| 03/16/2005 | EP1514106A1 Targeted therapeutic proteins |
| 03/16/2005 | EP1514104A1 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species |
| 03/16/2005 | EP1513951A2 Cancer-linked gene as target for chemotherapy |
| 03/16/2005 | EP1513875A2 Krib polynucleotides and polypeptides and uses thereof in the treatment of metabolic disorders |
| 03/16/2005 | EP1513874A2 Compositions and methods of use for a bombesin peptide |
| 03/16/2005 | EP1513873A2 Therapeutic epitopes and uses thereof |
| 03/16/2005 | EP1513870A2 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis and methods and products for detecting and/or identifying same |
| 03/16/2005 | EP1513865A2 Crisp polypeptides as contraceptives and inhibitors of sperm capacitation |
| 03/16/2005 | EP1513864A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/16/2005 | EP1513859A2 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 03/16/2005 | EP1513853A2 Cardiolipin compositions, methods of preparation and use |
| 03/16/2005 | EP1513814A1 Novel piperidine compound |
| 03/16/2005 | EP1513811A1 Non-peptidic brs-3 agonists |
| 03/16/2005 | EP1513797A1 Agents and methods for the treatment of disorders associated with oxidative stress |
| 03/16/2005 | EP1513558A2 METHODS AND COMPOSITION FOR MODULATING TYPE I MUSCLE FORMATION USING PGC-1alpha |
| 03/16/2005 | EP1513557A2 Compositions for the transport of therapeutic molecules into the lungs and use thereof for the treatment of lung cancers and pulmonary diseases |
| 03/16/2005 | EP1513553A1 Methods and materials for treating inflammatory conditions |
| 03/16/2005 | EP1513549A2 Human prolactin antagonist-angiogenesis inhibitor fusion proteins |
| 03/16/2005 | EP1513548A2 Method for reducing obstructive hydrocephalus |
| 03/16/2005 | EP1513547A2 Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy |
| 03/16/2005 | EP1513546A1 Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone |
| 03/16/2005 | EP1513545A2 Methods and means to promote gut absorption |
| 03/16/2005 | EP1513544A2 Retroyclins: antiviral and antimicrobial peptides |
| 03/16/2005 | EP1513543A2 Fas peptide mimetics and uses thereof |
| 03/16/2005 | EP1513542A2 Anti-cancer and wound healing compounds |
| 03/16/2005 | EP1513538A2 Novel methods for the delivery of polynucleotides to cells |
| 03/16/2005 | EP1513522A2 Methods of treating conditions associated with an edg receptor |
| 03/16/2005 | EP1513502A1 Combination therapy for respiratory disorders |
| 03/16/2005 | EP1513419A2 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 03/16/2005 | EP1513404A1 Intramyocardial injection of autologous bone marrow |
| 03/16/2005 | EP1470216A4 Hair follicle growth |
| 03/16/2005 | EP1353929B1 Streptogramin derivatives preparation thereof and compositions containing same |
| 03/16/2005 | EP1339421B1 Cosmetic and/or dermopharmaceutical preparations containing native proteins from the plant argania spinosa |
| 03/16/2005 | EP1268784B1 Genes involved in intestinal inflammatory diseases and use thereof |
| 03/16/2005 | EP1250358B1 Therapeutic peptides |
| 03/16/2005 | EP1204423B1 Therapeutic antibody against muc-1 antigen and methods for their use |
| 03/16/2005 | EP1171143B9 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same |
| 03/16/2005 | EP1044016B1 Stabilised insulin compositions |
| 03/16/2005 | EP1037923B1 Method for preparing by filtration a virally secure factor viii solution |
| 03/16/2005 | EP1003775B1 Hepatitis c inhibitor peptides |
| 03/16/2005 | EP0952772B1 Methods of use of mononuclear phagocytes to promote axonal regeneration |
| 03/16/2005 | EP0948609B1 Llg polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies |
| 03/16/2005 | EP0942746B1 Inhibition of invasive remodelling |
| 03/16/2005 | EP0907737B1 Il-6 mutein |
| 03/16/2005 | EP0869966B1 Prodrugs of thrombin inhibitors |
| 03/16/2005 | EP0808164B1 Use of prolactin modulators and diet for the manufacture of a medicament for the treatment of obesity |
| 03/16/2005 | EP0774964B1 Controlled local delivery of chemotherapeutic agents for treating solid tumors |
| 03/16/2005 | EP0744027B1 Use of methods for identifying hydrophilic signal oligopeptides |
| 03/16/2005 | EP0721783B1 Preventive and remedy for diseases caused by fibrinoid or thrombus formation in the lung |
| 03/16/2005 | EP0716604B1 Thiol-derivatized nucleosides and oligonucleosides |
| 03/16/2005 | CN1596371A Novel self-assembly molecules |
| 03/16/2005 | CN1596310A Method for producing a recombinant polypeptide |
| 03/16/2005 | CN1596309A Recombinant DNA encoding the major allergen of plantago lanceolata pollen, PLA L 1, and applications thereof |
| 03/16/2005 | CN1596303A Methods and compositions for the use of stromal cells to support embryonic and adult stem cells |
| 03/16/2005 | CN1596269A A novel G protein-coupled receptor, gave 10 |
| 03/16/2005 | CN1596266A Specific binding agents of human angiopoietin-2 |
| 03/16/2005 | CN1596264A Differentially expressed genes associated with obesity and type 2 diabetes |
| 03/16/2005 | CN1596248A Phenoxy amine compounds and compositions for delivering active agents |
| 03/16/2005 | CN1596130A Genetic remedies for neurodegenerative diseases |
| 03/16/2005 | CN1596127A Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 03/16/2005 | CN1596125A Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides |
| 03/16/2005 | CN1596124A Delivery system for biological component |
| 03/16/2005 | CN1596123A Interferon therapeutic effect-potentiating agents |
| 03/16/2005 | CN1596122A Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides |
| 03/16/2005 | CN1596121A Prevention and treatment of restenosis by local administration of drug |
| 03/16/2005 | CN1596120A Medicinal compositions for nasal absorption |
| 03/16/2005 | CN1596119A Modification of feeding behavior |
| 03/16/2005 | CN1596116A Anticancer compositions |
| 03/16/2005 | CN1596111A Methods and compositions for ameliorating the undesirable effects of chemotherapy |
| 03/16/2005 | CN1594587A Preparation for fungus extracellular polysaccharide compound and application thereof |
| 03/16/2005 | CN1594580A New genetic engineering drug for multi-target inhibiting growth of tumor |
| 03/16/2005 | CN1594578A Sea anemone neurotoxin gene Sr3 and application thereof |
| 03/16/2005 | CN1594577A Sea anemone neurotoxin gene Sr4 and application thereof |
| 03/16/2005 | CN1594576A Sea anemone neurotoxin gene Sr5 and application thereof |
| 03/16/2005 | CN1594575A Sea anemone neurotoxin gene Sr6 and application thereof |
| 03/16/2005 | CN1594574A Sea anemone neurotoxin gene Sr2 and application thereof |
| 03/16/2005 | CN1594573A Sea anemone neurotoxin gene Sr1 and application thereof |
| 03/16/2005 | CN1594572A Sea anemone neurotoxin gene Sr7 and application thereof |
| 03/16/2005 | CN1594567A Immune tbid gene, encoded protein and use thereof |
| 03/16/2005 | CN1594360A Red cashew nut legumin and its preparation and use |
| 03/16/2005 | CN1594358A Method for reducing or inhibition of proliferation of oncogenic cells and compound used in it (variants) |
| 03/16/2005 | CN1594357A Immune regulatory gene extracting method and use in preparation of drug for treating barrenness |
| 03/16/2005 | CN1593656A Natural hirudin compound medicinal health products |
| 03/16/2005 | CN1593655A Leading thrombolysis agent, preparation method and application thereof |
| 03/16/2005 | CN1593654A Human lysozyme suppository, preparation method and application |
| 03/16/2005 | CN1593653A Human lysozyme pellicle, preparation method and application |
| 03/16/2005 | CN1593652A Usage of human lysozyme in preparation of dermics |
| 03/16/2005 | CN1593651A Novel usage of human antalzyme in the process for preparing ophthalmopathy treating medicine |
| 03/16/2005 | CN1593650A Effervescence tablet of human antalzyme, its preparation and usage |
| 03/16/2005 | CN1593649A Method for preparing insulin oral formulation |
| 03/16/2005 | CN1593648A Buccal tablet of recombined human interferon alpha 1 b and its preparation |
| 03/16/2005 | CN1593647A Nutrient and healthy capsule of active ass hide |
| 03/16/2005 | CN1593646A Soybean peptide, its preparation and application |
| 03/16/2005 | CN1593250A Animal polypeptide containing bee honeydew |